In previous studies, we reported that the humanized IgG1 mAb NEO-201 reacts against numerous carcinomas expressing tumor-associated variants of CEACAM5 and CEACAM6, but it is not reactive against most normal epithelial tissues. The gene discussed is CEACAM5; the disease is neoplasm.